Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) has been assigned a consensus recommendation of "Buy...
In a groundbreaking study, scientists at Scripps Research and aTyr Pharma have unveiled promising in...
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage bio...
Knott David M Jr acquired a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in th...
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) saw a large growth in short interest during the mont...